Sfoglia per Autore
Dimensions of psychological dysfunction in patients with fibromyalgia: development of an Italian questionnaire.
2004 COLANGELO N; BERTINOTTI L; NACCI F; CONFORTI ML; BENEFORTI E; PIGNONE A; MATUCCI CERINIC M; ZOPPI M.
Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study.
2004 LEVY Y; AMITAL H; LANGEVITZ P; NACCI F; RIGHI A; CONFORTI L; GENERINI S; MATUCCI CERINIC M; SHOENFELD Y.
Utilità di un programma di controllo della safety in pazienti in terapia con anti-TNF
2005 F. Nacci; I. Miniati; D. Melchiorre; C. Ceccarelli; F. Bandinelli; C. Marinotti; M.L. Conforti; F. Bartoli; S. Guiducci; R. Fedi; S. Generini; G. Fiori; S. Maddali Bongi; A. Moggi Pignone; M. Matucci Cerinic
The measurement of outcome and the rheumatoid arthritis core set to lift the prejudice of the 'thaumaturgus cliche'.
2006 BERTINOTTI L; NACCI F; MATUCCI CERINIC M
Thin-section and low-dose volumetric computed tomographic densitometry of the lung in systemic sclerosis.
2006 ORLANDI I.; CAMICIOTTOLI G.; DICIOTTI S.; BARTOLUCCI M.; CAVIGLI E.; NACCI F.; MATUCCI CERINIC M.; VILLARI N.; MASCALCHI M
Humira riduce lo spessore della sinovia in pazienti affetti da artrite reumatoide
2006 F. Nacci; R. Fedi; S. Generini; S. Maddali Bongi; D. Melchiorre; M. Zoppi; A. Moggi Pignone; M. Matucci Cerinic
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.
2007 Mancarella L;Bobbio-Pallavicini F;Ceccarelli F;Falappone PC;Ferrante A;Malesci D;Massara A;Nacci F;Secchi ME;Manganelli S;Salaffi F;Bambara ML;Bombardieri S;Cutolo M;Ferri C;Galeazzi M;Gerli R;Giacomelli R;Grassi W;Lapadula G;Cerinic MM;Montecucco C;Trotta F;Triolo G;Valentini G;Valesini G;Ferraccioli GF;GISEA group
A 10-year follow-up of alendronate-treated young patients
2007 Cimaz, R; Bianchi, Ml; Biggioggero, M; Buoncompagni, A; Corona, F; Falcini, F; Lepore, L; Zulian, F; Nacci, F; Beltramelli, M
Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study.
2007 Nacci F; Righi A; Conforti ML; Miniati I; Fiori G; Martinovic D; Melchiorre D; Sapir T; Blank M; Shoenfeld Y; Pignone AM; Cerinic MM.
Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA)
2008 Falcini, F; Capannini, S; Tonini, G; Nacci, F; Simonini, G; Cimaz, R; Stagi, S
FAS/FASL and TF/FVII Levels In Rheumatoid Arthritis Patients Treated With TNF Antagonists
2009 Guiducci, S.; Nacci, F.; Bartoli, F.; Romano, E.; Ceccarelli, C.; Fiori, G.; Sacu, O.; Maddali Bongi, S.; Matucci Cerinic, M.
Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis
2009 Maddali Bongi S; Del Rosso A; Galluccio F; Sigismondi F; Miniati I; Conforti ML; Nacci F; Matucci Cerinic M
Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study.
2009 Falcini F; Capannini S; Martini G; La Torre F; Vitale A; Mangiantini F; Nacci F; Cerinic MM; Cimaz R; Zulian F.
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study).
2010 Scarpato S; Antivalle M; Favalli EG; Nacci F; Frigelli S; Bartoli F; Bazzichi L; Minisola G; Matucci Cerinic M; RIVIERA co-authors
Prevalence of Fibromyalgia: A Survey in Five European Countries.
2010 Branco JC; Bannwarth B; Failde I; Abello Carbonell J; Blotman F; Spaeth M; Saraiva F; Nacci F; Thomas E; Caubère JP; Le Lay K; Taieb C; Matucci-Cerinic M.
Sonographic evaluation of the temporomandibular joints in juvenile idiopathic arthritis
2010 Melchiorre D.; Falcini F.; Kaloudi O.; Bandinelli F.; Nacci F.; Matucci Cerinic M.
Tuberculosis and other infections in the anti-tumour necrosis factor-alpha (anti-TNF-α) era.
2011 Nacci F;Matucci Cerinic M
Quantiferon (QFT) identifies latent tuberculosis (LTB) but does not help the evaluation of the efficacy of prophylaxis in inflammatory arthritides
2012 Peruzzi, F.; Bartalesi, F.; Attala, L.; Cavallo, A.; Fiori, G.; Maddali-Bongi, S.; Bruni, C.; Nacci, F.; Bartoli, F.; Cappelli, S.; Denaro, V.; Bartoloni, A.; Matucci-Cerinic, M.
Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production.
2013 Terenzi R;Romano E;Manetti M;Peruzzi F;Nacci F;Matucci-Cerinic M;Guiducci S
Transitional connective tissue diseases: description of four cases
2014 Susanna, Cappelli; Philippe, Guilpain; Silvia, Bellando-Randone; Ginevra, Fiori; Francesca, Bartoli; Jelena, Blagojevic; Francesca, Nacci; Letizia, Conforti Maria; Francesca, Braschi; Loic, Guillevin; Marco, Matucci-Cerinic
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Dimensions of psychological dysfunction in patients with fibromyalgia: development of an Italian questionnaire. | 2004 | COLANGELO N; BERTINOTTI L; NACCI F; CONFORTI ML; BENEFORTI E; PIGNONE A; MATUCCI CERINIC M; ZOPPI M. | |
| Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study. | 2004 | LEVY Y; AMITAL H; LANGEVITZ P; NACCI F; RIGHI A; CONFORTI L; GENERINI S; MATUCCI CERINIC M; SHOENFELD Y. | |
| Utilità di un programma di controllo della safety in pazienti in terapia con anti-TNF | 2005 | F. Nacci; I. Miniati; D. Melchiorre; C. Ceccarelli; F. Bandinelli; C. Marinotti; M.L. Conforti; F. Bartoli; S. Guiducci; R. Fedi; S. Generini; G. Fiori; S. Maddali Bongi; A. Moggi Pignone; M. Matucci Cerinic | |
| The measurement of outcome and the rheumatoid arthritis core set to lift the prejudice of the 'thaumaturgus cliche'. | 2006 | BERTINOTTI L; NACCI F; MATUCCI CERINIC M | |
| Thin-section and low-dose volumetric computed tomographic densitometry of the lung in systemic sclerosis. | 2006 | ORLANDI I.; CAMICIOTTOLI G.; DICIOTTI S.; BARTOLUCCI M.; CAVIGLI E.; NACCI F.; MATUCCI CERINIC M.; VILLARI N.; MASCALCHI M | |
| Humira riduce lo spessore della sinovia in pazienti affetti da artrite reumatoide | 2006 | F. Nacci; R. Fedi; S. Generini; S. Maddali Bongi; D. Melchiorre; M. Zoppi; A. Moggi Pignone; M. Matucci Cerinic | |
| Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. | 2007 | Mancarella L;Bobbio-Pallavicini F;Ceccarelli F;Falappone PC;Ferrante A;Malesci D;Massara A;Nacci F;Secchi ME;Manganelli S;Salaffi F;Bambara ML;Bombardieri S;Cutolo M;Ferri C;Galeazzi M;Gerli R;Giacomelli R;Grassi W;Lapadula G;Cerinic MM;Montecucco C;Trotta F;Triolo G;Valentini G;Valesini G;Ferraccioli GF;GISEA group | |
| A 10-year follow-up of alendronate-treated young patients | 2007 | Cimaz, R; Bianchi, Ml; Biggioggero, M; Buoncompagni, A; Corona, F; Falcini, F; Lepore, L; Zulian, F; Nacci, F; Beltramelli, M | |
| Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study. | 2007 | Nacci F; Righi A; Conforti ML; Miniati I; Fiori G; Martinovic D; Melchiorre D; Sapir T; Blank M; Shoenfeld Y; Pignone AM; Cerinic MM. | |
| Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA) | 2008 | Falcini, F; Capannini, S; Tonini, G; Nacci, F; Simonini, G; Cimaz, R; Stagi, S | |
| FAS/FASL and TF/FVII Levels In Rheumatoid Arthritis Patients Treated With TNF Antagonists | 2009 | Guiducci, S.; Nacci, F.; Bartoli, F.; Romano, E.; Ceccarelli, C.; Fiori, G.; Sacu, O.; Maddali Bongi, S.; Matucci Cerinic, M. | |
| Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis | 2009 | Maddali Bongi S; Del Rosso A; Galluccio F; Sigismondi F; Miniati I; Conforti ML; Nacci F; Matucci Cerinic M | |
| Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study. | 2009 | Falcini F; Capannini S; Martini G; La Torre F; Vitale A; Mangiantini F; Nacci F; Cerinic MM; Cimaz R; Zulian F. | |
| Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study). | 2010 | Scarpato S; Antivalle M; Favalli EG; Nacci F; Frigelli S; Bartoli F; Bazzichi L; Minisola G; Matucci Cerinic M; RIVIERA co-authors | |
| Prevalence of Fibromyalgia: A Survey in Five European Countries. | 2010 | Branco JC; Bannwarth B; Failde I; Abello Carbonell J; Blotman F; Spaeth M; Saraiva F; Nacci F; Thomas E; Caubère JP; Le Lay K; Taieb C; Matucci-Cerinic M. | |
| Sonographic evaluation of the temporomandibular joints in juvenile idiopathic arthritis | 2010 | Melchiorre D.; Falcini F.; Kaloudi O.; Bandinelli F.; Nacci F.; Matucci Cerinic M. | |
| Tuberculosis and other infections in the anti-tumour necrosis factor-alpha (anti-TNF-α) era. | 2011 | Nacci F;Matucci Cerinic M | |
| Quantiferon (QFT) identifies latent tuberculosis (LTB) but does not help the evaluation of the efficacy of prophylaxis in inflammatory arthritides | 2012 | Peruzzi, F.; Bartalesi, F.; Attala, L.; Cavallo, A.; Fiori, G.; Maddali-Bongi, S.; Bruni, C.; Nacci, F.; Bartoli, F.; Cappelli, S.; Denaro, V.; Bartoloni, A.; Matucci-Cerinic, M. | |
| Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. | 2013 | Terenzi R;Romano E;Manetti M;Peruzzi F;Nacci F;Matucci-Cerinic M;Guiducci S | |
| Transitional connective tissue diseases: description of four cases | 2014 | Susanna, Cappelli; Philippe, Guilpain; Silvia, Bellando-Randone; Ginevra, Fiori; Francesca, Bartoli; Jelena, Blagojevic; Francesca, Nacci; Letizia, Conforti Maria; Francesca, Braschi; Loic, Guillevin; Marco, Matucci-Cerinic |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile